Cabrera et al., 2024 - Google Patents
Maturing neutrophils of lower density associate with thrombocytopenia in Puumala orthohantavirus-caused hemorrhagic fever with renal syndromeCabrera et al., 2024
View HTML- Document ID
- 14821023703915135799
- Author
- Cabrera L
- Tietäväinen J
- Jokiranta S
- Mäkelä S
- Vaheri A
- Mustonen J
- Vapalahti O
- Kanerva M
- Strandin T
- Publication year
- Publication venue
- Frontiers in Immunology
External Links
Snippet
Puumala orthohantavirus-caused hemorrhagic fever with renal syndrome (PUUV-HFRS) is characterized by strong neutrophil activation. Neutrophils are the most abundant immune cell type in the circulation and are specially equipped to rapidly respond to infections. They …
- 210000000440 neutrophil 0 title abstract description 84
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
- G06F17/30—Information retrieval; Database structures therefor; File system structures therefor
- G06F17/30286—Information retrieval; Database structures therefor; File system structures therefor in structured data stores
- G06F17/30386—Retrieval requests
- G06F17/30424—Query processing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Electro-optical investigation, e.g. flow cytometers
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Melms et al. | A molecular single-cell lung atlas of lethal COVID-19 | |
Kvedaraite et al. | Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity | |
Combes et al. | Global absence and targeting of protective immune states in severe COVID-19 | |
Cabrera et al. | Characterization of low-density granulocytes in COVID-19 | |
Lourda et al. | High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19 | |
Steele et al. | Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer | |
Xu et al. | The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing | |
Tian et al. | Single-cell immunology of SARS-CoV-2 infection | |
Cader et al. | A peripheral immune signature of responsiveness to PD-1 blockade in patients with classical Hodgkin lymphoma | |
Hu et al. | Transcriptional signature of human pro-inflammatory TH17 cells identifies reduced IL10 gene expression in multiple sclerosis | |
Lakshmikanth et al. | Mass cytometry and topological data analysis reveal immune parameters associated with complications after allogeneic stem cell transplantation | |
Lu et al. | Tumor-associated hematopoietic stem and progenitor cells positively linked to glioblastoma progression | |
Peyneau et al. | Innate immune deficiencies are associated with severity and poor prognosis in patients with COVID-19 | |
Lo Tartaro et al. | Molecular and cellular immune features of aged patients with severe COVID-19 pneumonia | |
Shenoi et al. | Comparison of biomarkers for systemic juvenile idiopathic arthritis | |
Van Unen et al. | Identification of a disease-associated network of intestinal immune cells in treatment-naive inflammatory bowel disease | |
Navas et al. | Phenotypic and functional stability of leukocytes from human peripheral blood samples: considerations for the design of immunological studies | |
Jones et al. | ANCA autoantigen gene expression highlights neutrophil heterogeneity where expression in normal-density neutrophils correlates with ANCA-induced activation | |
Walter et al. | The relationship between peripheral immune response and disease severity in SARS‐CoV‐2‐infected subjects: A cross‐sectional study | |
Pickering et al. | NK and CD8+ T cell phenotypes predict onset and control of CMV viremia after kidney transplant | |
Palma Medina et al. | Targeted plasma proteomics reveals signatures discriminating COVID-19 from sepsis with pneumonia | |
Vangeti et al. | Monocyte subset redistribution from blood to kidneys in patients with Puumala virus caused hemorrhagic fever with renal syndrome | |
Lemaitre et al. | Mass cytometry reveals the immaturity of circulating neutrophils during SIV infection | |
Plužarić et al. | Differential skewing of circulating MR1-restricted and γδ T cells in human psoriasis vulgaris | |
Reyes et al. | Induction of a regulatory myeloid program in bacterial sepsis and severe COVID-19 |